Mylan $60,000,000 Securities Class Action Settlement
Mylan $60,000,000 Securities Class Action Settlement

Investors who purchased or otherwise acquired publicly traded common stock of Mylan N.V. between Feb. 16, 2016, and May 7, 2019, may be eligible to claim a cash payment from a class action settlement.

Mylan N.V. and certain former executives agreed to pay $60 million to settle a securities class action lawsuit alleging they made false and misleading statements related to U.S. Food and Drug Administration inspections and regulatory compliance at some of the company's facilities.

Who can file a claim?

The settlement class includes all persons and entities who purchased or otherwise acquired publicly traded common stock of Mylan N.V. (NASDAQ: MYL) between Feb. 16, 2016, and May 7, 2019, inclusive, and allegedly suffered damages as a result.

Additional details

  • Both individuals and entities can be class members.
  • Each separate legal entity or separately managed account must submit a separate claim.
  • Joint beneficial owners must each sign the claim form.
  • Agents, executors, administrators, guardians and trustees may submit claims on behalf of others and must provide proof of authority.
  • Participants in and beneficiaries of any employee retirement or benefit plan covered by ERISA should not include Mylan securities transactions made through an employee plan on an individual claim form.
  • Plan trustees must submit claims for employee plan transactions.

How much can class members get?

The total settlement fund is $60,000,000. The amount each class member will receive depends on several factors:

  • The number of valid claims submitted
  • The number of shares purchased or acquired during the class period
  • The timing of each purchase, sale and holding
  • The total recognized losses of all claimants

The settlement administrator will distribute payments on a pro rata basis according to the court-approved plan of allocation:

  • The estimated average recovery per allegedly damaged share is approximately $0.11 before deductions for attorneys' fees, expenses and other costs.
  • Actual payments may be higher or lower depending on individual claims and the total number of valid claims.
  • The settlement administrator will calculate each class member's payment based on the recognized loss amount assigned to each transaction.
  • Recognized loss amounts depend on purchase and sale timing. The settlement administrator will calculate them using the court-approved plan of allocation, which applies different formulas based on estimated artificial inflation per share at the time of purchase and sale (see Table A and Table B on pages 20-21 of the settlement notice).
    • For shares sold before 12:01 p.m. Eastern time on June 27, 2018, the recognized loss amount is $0.
    • For shares sold at or after 12:01 p.m. Eastern time on June 27, 2018, through May 6, 2019, the recognized loss amount is the lesser of the difference in artificial inflation per share on the purchase and sale dates or the purchase price minus the sale price.
    • For shares sold from May 7, 2019, through Aug. 2, 2019, the recognized loss amount is the least of the artificial inflation per share on the purchase date, the purchase price minus the average closing price from May 7, 2019, through the date of sale or the purchase price minus the sale price.
    • For shares held as of the close of trading on Aug. 2, 2019, the recognized loss amount is the lesser of the artificial inflation per share on the purchase date or the purchase price minus $18.93 (the mean closing price during the 90-day look-back period).
  • The settlement administrator will set any recognized loss amount that calculates to a negative number to $0.
  • Claimants who had an overall market gain on Mylan transactions during the class period will not have a recognized claim.
  • If total recognized claims exceed the net settlement fund, the settlement administrator will reduce payments on a pro rata basis.
  • Class members whose payment would be less than $10 will not receive a payout.

How to claim a Mylan securities class action settlement payment

Class members may file a claim online or download, print and complete the PDF claim form and mail it to the settlement administrator. The deadline to file a claim is July 10, 2026.

Settlement administrator's mailing address: Mylan Securities Litigation, c/o JND Legal Administration, P.O. Box 91088, Seattle, WA 98111

Proof or documentation required to submit a claim

All class members must provide the last four digits of their Social Security number or taxpayer identification number. They must also provide purchase, acquisition and sale information, including:

  • Holdings of Mylan common stock as of the opening of trading on Feb. 16, 2016
  • Purchases and acquisitions of Mylan common stock from Feb. 16, 2016, through May 7, 2019
  • Purchases and acquisitions of Mylan common stock from May 8, 2019, through Aug. 2, 2019
  • Sales of Mylan common stock from Feb. 16, 2016, through Aug. 2, 2019
  • Holdings of Mylan common stock as of the close of trading on Aug. 2, 2019

Class members must also provide documentation to support their transactions in Mylan common stock. Acceptable proof includes:

  • Trade confirmations
  • Monthly account statements
  • Authorized statements from a broker or financial institution containing the transactional and holding information found in a trade confirmation or account statement

Payout options

  • Physical check

$60 million settlement fund

The $60,000,000 settlement fund includes:

  • Settlement administration costs: To be determined
  • Attorneys' fees: Up to $15,000,000
  • Attorneys' expenses: Up to $500,000
  • Payments to eligible class members: Remainder of the fund

Important dates

  • Opt-out deadline: May 15, 2026
  • Fairness hearing: June 15, 2026
  • Deadline to file a claim: July 10, 2026

When is the Mylan securities class action settlement payout date?

The settlement administrator will issue payments after it processes all claims and the court resolves any appeals and approves the settlement.

Why did this class action settlement happen?

The class action lawsuit alleged Mylan N.V. and certain former executives made false and misleading statements related to FDA inspections and regulatory compliance at certain of the company's facilities. The plaintiffs claimed these statements artificially inflated the price of Mylan common stock, causing investor losses when corrective information entered the market.

The defendants denied all allegations of wrongdoing but agreed to settle to avoid the costs, risks and delays of continued litigation.

Sources

  1. Class notice
  2. Claim form
  3. Official settlement website FAQ page
Settlement Open for Claims
Award:
$0.11 per share before deductions
Deadline:
July 10, 2026
SUBMIT CLAIM